Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1998Leukemia & lymphoma/Leukemia and lymphoma

Molecular Monitoring of Minimal Residual Disease in Acute Myeloblastic Leukemia with t(8;21) by RT-PCR

View Full Paper
Ask AI
Bookmark
Share

Authors

KTKhalid TobalDebiopharm (Switzerland)JYJohn A. Liu YinManchester Royal Infirmary

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tobal et al. (1998) studied this question.

synapsesocial.com/papers/6a106c534fb650da4fff7181https://doi.org/10.3109/10428199809057591
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Polyclonal haemopoieses associated with long‐term persistence of the AML1‐ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission1995 · 28 citations
  2. 2Disappearance of AML1 ‐MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long‐term remission1995 · 60 citations
  3. 3Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt1992 · 578 citations
  4. 4Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission1993 · 291 citations